The way we balance [risk], is we put ourselves at risk. We’re the largest investors in our funds. 25 cents on every dollar, which is painful, but it forces us to make these important decisions about where we stand on these issues, morally.
If we stand on the side of saying, “We came to this with a mission and a purpose to fix a problem, to create a structural solution to reducing A1C, or to create the pathway for people with asthma and COPD to not suffer from chronic respiratory issues, or people that have cancer to actually get the best quality of care using cutting edge genetics and genomics,” then that’s what we do.
When there’s discomfort, then we have to find other capital partners who believe what we believe.
We can’t capitulate at the 11th hour.
This doesn’t mean everything is going to work, and it doesn’t mean we make all the right decisions all the time.
We’ve done so many things that have made short term massive profits, that’s why we especially have to go to the extreme on the other side. Because if we don’t, nobody is going to be there. And this stuff will die on the vine. That’s not right.